► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs<br /><br />Lex’s Alan Livsey and Giles Wilkes discuss the decision by the US Treasury to remove the benefit of shifting a company’s tax residence abroad, and how this will affect the recent deal between pharmaceutical companies Allergan and Pfizer.<br /><br />For more video content from the Financial Times, visit http://www.FT.com/video<br /><br /><br />Twitter https://twitter.com/ftvideo<br />Facebook https://www.facebook.com/financialtimes
